Cargando…
Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins
The aspariginyl hydroxylase human factor inhibiting hypoxia-inducible factor (FIH) is an important regulator of the transcriptional activity of hypoxia-inducible factor. FIH also catalyzes the hydroxylation of asparaginyl and other residues in ankyrin repeat domain–containing proteins, including apo...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189129/ https://www.ncbi.nlm.nih.gov/pubmed/35537551 http://dx.doi.org/10.1016/j.jbc.2022.102020 |
_version_ | 1784725516183404544 |
---|---|
author | Leissing, Thomas M. Hardy, Adam P. Chan, Hokfung Wang, Yihua Tumber, Anthony Chowdhury, Rasheduzzaman Feng, Tianshu Coleman, Mathew L. Cockman, Matthew E. Kramer, Holger B. Berridge, Georgina Fischer, Roman Kessler, Benedikt M. Ratcliffe, Peter J. Lu, Xin Schofield, Christopher J. |
author_facet | Leissing, Thomas M. Hardy, Adam P. Chan, Hokfung Wang, Yihua Tumber, Anthony Chowdhury, Rasheduzzaman Feng, Tianshu Coleman, Mathew L. Cockman, Matthew E. Kramer, Holger B. Berridge, Georgina Fischer, Roman Kessler, Benedikt M. Ratcliffe, Peter J. Lu, Xin Schofield, Christopher J. |
author_sort | Leissing, Thomas M. |
collection | PubMed |
description | The aspariginyl hydroxylase human factor inhibiting hypoxia-inducible factor (FIH) is an important regulator of the transcriptional activity of hypoxia-inducible factor. FIH also catalyzes the hydroxylation of asparaginyl and other residues in ankyrin repeat domain–containing proteins, including apoptosis stimulating of p53 protein (ASPP) family members. ASPP2 is reported to undergo a single FIH-catalyzed hydroxylation at Asn-986. We report biochemical and crystallographic evidence showing that FIH catalyzes the unprecedented post-translational hydroxylation of both asparaginyl residues in “VNVN” and related motifs of ankyrin repeat domains in ASPPs (i.e., ASPP1, ASPP2, and iASPP) and the related ASB11 and p18-INK4C proteins. Our biochemical results extend the substrate scope of FIH catalysis and may have implications for its biological roles, including in the hypoxic response and ASPP family function. |
format | Online Article Text |
id | pubmed-9189129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-91891292022-06-16 Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins Leissing, Thomas M. Hardy, Adam P. Chan, Hokfung Wang, Yihua Tumber, Anthony Chowdhury, Rasheduzzaman Feng, Tianshu Coleman, Mathew L. Cockman, Matthew E. Kramer, Holger B. Berridge, Georgina Fischer, Roman Kessler, Benedikt M. Ratcliffe, Peter J. Lu, Xin Schofield, Christopher J. J Biol Chem Research Article The aspariginyl hydroxylase human factor inhibiting hypoxia-inducible factor (FIH) is an important regulator of the transcriptional activity of hypoxia-inducible factor. FIH also catalyzes the hydroxylation of asparaginyl and other residues in ankyrin repeat domain–containing proteins, including apoptosis stimulating of p53 protein (ASPP) family members. ASPP2 is reported to undergo a single FIH-catalyzed hydroxylation at Asn-986. We report biochemical and crystallographic evidence showing that FIH catalyzes the unprecedented post-translational hydroxylation of both asparaginyl residues in “VNVN” and related motifs of ankyrin repeat domains in ASPPs (i.e., ASPP1, ASPP2, and iASPP) and the related ASB11 and p18-INK4C proteins. Our biochemical results extend the substrate scope of FIH catalysis and may have implications for its biological roles, including in the hypoxic response and ASPP family function. American Society for Biochemistry and Molecular Biology 2022-05-07 /pmc/articles/PMC9189129/ /pubmed/35537551 http://dx.doi.org/10.1016/j.jbc.2022.102020 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Leissing, Thomas M. Hardy, Adam P. Chan, Hokfung Wang, Yihua Tumber, Anthony Chowdhury, Rasheduzzaman Feng, Tianshu Coleman, Mathew L. Cockman, Matthew E. Kramer, Holger B. Berridge, Georgina Fischer, Roman Kessler, Benedikt M. Ratcliffe, Peter J. Lu, Xin Schofield, Christopher J. Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins |
title | Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins |
title_full | Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins |
title_fullStr | Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins |
title_full_unstemmed | Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins |
title_short | Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins |
title_sort | factor inhibiting hif can catalyze two asparaginyl hydroxylations in vnvn motifs of ankyrin fold proteins |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189129/ https://www.ncbi.nlm.nih.gov/pubmed/35537551 http://dx.doi.org/10.1016/j.jbc.2022.102020 |
work_keys_str_mv | AT leissingthomasm factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT hardyadamp factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT chanhokfung factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT wangyihua factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT tumberanthony factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT chowdhuryrasheduzzaman factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT fengtianshu factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT colemanmathewl factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT cockmanmatthewe factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT kramerholgerb factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT berridgegeorgina factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT fischerroman factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT kesslerbenediktm factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT ratcliffepeterj factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT luxin factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins AT schofieldchristopherj factorinhibitinghifcancatalyzetwoasparaginylhydroxylationsinvnvnmotifsofankyrinfoldproteins |